COVID Breath Test - Ancon
Breath Test Feasibility Trial for COVID-19 Infection Diagnosis
1 other identifier
observational
100
1 country
1
Brief Summary
This study is designed to look at the effectiveness of a new technology call Nanotechnology Biomarker Tagging (NBT) in detecting COVID-19 infection using breath samples of patients. Participation in this study is expected to take less than one month and will consist of a breath sample being taken by the research team, a cheek swab being taken by the research team, a questionnaire that will be completed by the participant with the help of the research teams, and a review of your medical record.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 16, 2020
CompletedFirst Submitted
Initial submission to the registry
February 10, 2021
CompletedFirst Posted
Study publicly available on registry
February 18, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 16, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 20, 2022
CompletedNovember 14, 2022
November 1, 2022
1.8 years
February 10, 2021
November 10, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Provide an adequate sample and compare the signals given from the two groups.
The samples from the participants will be analyzed to identify the different signals given from Covid-19 positive patients and Covid-19 negative patients
10 minutes
Study Arms (1)
Test group
Participants who have a positive Covid-19 Test or negative Covid-19 test who provide a breath sample.
Interventions
Eligibility Criteria
The study population will consist of particpants who are receiving Covid-19 testing, as well as in-patient and out-patients with Covid-19.
You may qualify if:
- Age 18 years and older
- Patients that present for COVID-19 testing, have tested Covid negative, or Covid Positive patients.
You may not qualify if:
- Unable to consent
- Patients on a ventilator
- Pregnant Women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Medical University of South Carolina
Charleston, South Carolina, 29425, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Medicine
Study Record Dates
First Submitted
February 10, 2021
First Posted
February 18, 2021
Study Start
December 16, 2020
Primary Completion
September 16, 2022
Study Completion
September 20, 2022
Last Updated
November 14, 2022
Record last verified: 2022-11
Data Sharing
- IPD Sharing
- Will not share